LATS1 and ulcerative colitis: Mechanically, miR-590-3p targets large tumor suppressor kinase 1 (LATS1) and then activates the Yes-associated protein (YAP)/β-catenin pathway, thereby reducing inflammatory release, improving wound healing ability of epithelial cells, and alleviating ulcerative colitis (33).